These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1278717)

  • 21. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD; Zilly W; Richter E
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy and clinical utility of simplified tests of antipyrine metabolism.
    Farrell GC; Zaluzny L
    Br J Clin Pharmacol; 1984 Oct; 18(4):559-65. PubMed ID: 6487495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of hepatic drug metabolism in alcoholics.
    Harman AW; Frewin DB; Priestly BG; Alexander CB
    Br J Clin Pharmacol; 1979 Jan; 7(1):45-8. PubMed ID: 760741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
    Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
    Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipyrin clearance in homozygous beta-thalassemia.
    Rifkind AB; Canale V; New MI
    Clin Pharmacol Ther; 1976 Oct; 20(4):476-83. PubMed ID: 975719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of pindolol in liver disease.
    Ohnhaus EE; Münch U; Meier J
    Eur J Clin Pharmacol; 1982; 22(3):247-51. PubMed ID: 7106158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of salivary concentration data to pharmacokinetic studies with antipyrine.
    Meffin PJ; Williams RL; Blaschke TF; Rowland M
    J Pharm Sci; 1977 Jan; 66(1):135-7. PubMed ID: 833730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of antipyrine kinetics by measurement in saliva.
    Fraser HS; Mucklow JC; Murray S; Davies DS
    Br J Clin Pharmacol; 1976 Apr; 3(2):321-5. PubMed ID: 973966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal drug metabolism after barbiturate and paracetamol overdose.
    Forrest JA; Roscoe P; Prescott LF; Stevenson IH
    Br Med J; 1974 Nov; 4(5943):499-502. PubMed ID: 4434117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipyrine disposition and liver size in the elderly.
    Swift CG; Homeida M; Halliwell M; Roberts CJ
    Eur J Clin Pharmacol; 1978 Nov; 14(2):149-52. PubMed ID: 720377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sources of interindividual variations in acetaminophen and antipyrine metabolism.
    Nash RM; Stein L; Penno MB; Passananti GT; Vesell ES
    Clin Pharmacol Ther; 1984 Oct; 36(4):417-30. PubMed ID: 6541104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of oral verapamil therapy on antipyrine clearance.
    Rumiantsev DO; Piotrovskii VK; Riabokon OS; Slastnikova ID; Kokurina EV; Metelitsa VI
    Br J Clin Pharmacol; 1986 Nov; 22(5):606-9. PubMed ID: 3790408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of fever on antipyrine oxidation in the rat.
    Aarbakke J; Gadeholt G; Olsen H
    Eur J Pharmacol; 1978 May; 49(1):31-7. PubMed ID: 658126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced drug metabolism in cigarette smokers.
    Hart P; Farrell GC; Cooksley WG; Powell LW
    Br Med J; 1976 Jul; 2(6028):147-9. PubMed ID: 1276835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.